[
  {
    "ts": "2025-12-10T00:11:27+00:00",
    "headline": "Johnson & Johnson (JNJ): Revisiting Valuation After a Strong Multi‑Month Share Price Rally",
    "summary": "Johnson & Johnson (JNJ) has quietly ground higher, with the stock up roughly 7% over the past month and nearly 14% in the past 3 months, drawing fresh attention from income focused investors. See our latest analysis for Johnson & Johnson. Zooming out, that steady climb sits on top of a powerful backdrop, with a roughly 39% year to date share price return and a three year total shareholder return above 22% suggesting momentum is still firmly building as investors reassess Johnson & Johnson’s...",
    "url": "https://finance.yahoo.com/news/johnson-johnson-jnj-revisiting-valuation-001127124.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "032baba9-f9f0-3958-912d-bf17b1929a9b",
      "content": {
        "id": "032baba9-f9f0-3958-912d-bf17b1929a9b",
        "contentType": "STORY",
        "title": "Johnson & Johnson (JNJ): Revisiting Valuation After a Strong Multi‑Month Share Price Rally",
        "description": "",
        "summary": "Johnson & Johnson (JNJ) has quietly ground higher, with the stock up roughly 7% over the past month and nearly 14% in the past 3 months, drawing fresh attention from income focused investors. See our latest analysis for Johnson & Johnson. Zooming out, that steady climb sits on top of a powerful backdrop, with a roughly 39% year to date share price return and a three year total shareholder return above 22% suggesting momentum is still firmly building as investors reassess Johnson & Johnson’s...",
        "pubDate": "2025-12-10T00:11:27Z",
        "displayTime": "2025-12-10T00:11:27Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4e8319e0e61499a110aef17faa48c1a7",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VmOStVnJjLnU3xikg4stLA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4e8319e0e61499a110aef17faa48c1a7.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/trESudVvS0UypUeXuQ_Yww--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4e8319e0e61499a110aef17faa48c1a7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-jnj-revisiting-valuation-001127124.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-jnj-revisiting-valuation-001127124.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-10T12:31:00+00:00",
    "headline": "JNJ vs. PFE: Which Blue-Chip Drug Stock is the Better Investment Now?",
    "summary": "JNJ and PFE battle patent cliffs and policy headwinds, but rising estimates and stronger 2025 momentum push JNJ ahead in this blue-chip faceoff.",
    "url": "https://finance.yahoo.com/news/jnj-vs-pfe-blue-chip-123100822.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "8b59f587-2747-3b59-8772-5695fe2d24b7",
      "content": {
        "id": "8b59f587-2747-3b59-8772-5695fe2d24b7",
        "contentType": "STORY",
        "title": "JNJ vs. PFE: Which Blue-Chip Drug Stock is the Better Investment Now?",
        "description": "",
        "summary": "JNJ and PFE battle patent cliffs and policy headwinds, but rising estimates and stronger 2025 momentum push JNJ ahead in this blue-chip faceoff.",
        "pubDate": "2025-12-10T12:31:00Z",
        "displayTime": "2025-12-10T12:31:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/afe95824683969079aeba27c8210bd37",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/O2fLjSeGpHAp4pnNFR6egw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/afe95824683969079aeba27c8210bd37.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qPY9mhd4gwuyP0ATgGKKxQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/afe95824683969079aeba27c8210bd37.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jnj-vs-pfe-blue-chip-123100822.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jnj-vs-pfe-blue-chip-123100822.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-10T16:28:40+00:00",
    "headline": "Johnson & Johnson (JNJ) Announces Updated Results From the Phase 3 CARTITUDE-4 Study",
    "summary": "Johnson & Johnson (NYSE:JNJ) is one of the best pharma stocks to invest in. Johnson & Johnson (NYSE:JNJ) announced on December 6 the updated results from the Phase 3 CARTITUDE-4 study that supported durable treatment-free remissions as early as second line treatment with CARVYKTI, reporting that the disease did not progress and no further treatment was […]",
    "url": "https://finance.yahoo.com/news/johnson-johnson-jnj-announces-updated-162840062.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "f145c487-e2d8-3682-9b09-556d10d9e64d",
      "content": {
        "id": "f145c487-e2d8-3682-9b09-556d10d9e64d",
        "contentType": "STORY",
        "title": "Johnson & Johnson (JNJ) Announces Updated Results From the Phase 3 CARTITUDE-4 Study",
        "description": "",
        "summary": "Johnson & Johnson (NYSE:JNJ) is one of the best pharma stocks to invest in. Johnson & Johnson (NYSE:JNJ) announced on December 6 the updated results from the Phase 3 CARTITUDE-4 study that supported durable treatment-free remissions as early as second line treatment with CARVYKTI, reporting that the disease did not progress and no further treatment was […]",
        "pubDate": "2025-12-10T16:28:40Z",
        "displayTime": "2025-12-10T16:28:40Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/f9ccf3c88c7274582ef19e20143427c2",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Barclays Raises Johnson & Johnson (JNJ) Price Target After Updated Estimates",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qG_90ptmVmYmlFzMjoC0Yw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/f9ccf3c88c7274582ef19e20143427c2.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Q3JcjOP_BI3o_9_ANEkK.w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/f9ccf3c88c7274582ef19e20143427c2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-jnj-announces-updated-162840062.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-jnj-announces-updated-162840062.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-10T19:15:15+00:00",
    "headline": "Stock Market Today: Dow Rises As Fed Cuts Rates, Powell Up Next; Palantir Jumps (Live Coverage)",
    "summary": "Stock Market Today: The Dow Jones index rises Wednesday after the Fed rate cut. Microsoft stock sold off.",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-sp500-nasdaq-fed-decision-powell-nvidia-tsm/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "d2a83895-3dec-3c32-978d-30d95c7a44de",
      "content": {
        "id": "d2a83895-3dec-3c32-978d-30d95c7a44de",
        "contentType": "STORY",
        "title": "Stock Market Today: Dow Rises As Fed Cuts Rates, Powell Up Next; Palantir Jumps (Live Coverage)",
        "description": "",
        "summary": "Stock Market Today: The Dow Jones index rises Wednesday after the Fed rate cut. Microsoft stock sold off.",
        "pubDate": "2025-12-10T19:15:15Z",
        "displayTime": "2025-12-10T19:15:15Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/d2a83895-3dec-3c32-978d-30d95c7a44de/stock-market-today-dow-rises.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/79f2a424f8eeab7d451565d80eae1db5",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5c4UjrehJHsiUMrdoCEp4g--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/79f2a424f8eeab7d451565d80eae1db5.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tDgenSeRz9BSRFgb0sysFg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/79f2a424f8eeab7d451565d80eae1db5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-sp500-nasdaq-fed-decision-powell-nvidia-tsm/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "CBRL"
            },
            {
              "symbol": "CHWY"
            },
            {
              "symbol": "TSM"
            },
            {
              "symbol": "GME"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "NKE"
            },
            {
              "symbol": "AXP"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "CRM"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "CSCO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]